(Total Views: 1168)
Posted On: 10/02/2017 1:30:26 PM
Post# of 1422
$EPGL is continuing to structure a relationship with a new start-up company called InWith Corporation as well as other major companies for the purpose of building selected EPGL technologies. The stated goal of InWith Corporation is to effect a major capital raise for the purposes of acquiring license and/or ownership to EPGL ophthalmic technologies and IP portfolio as well as a buyout offer for its shareholders.
EPGL has received multiple USPTO patent allowances and has several more pending both in the US and International. The granted patents include the “Elastic Circuit”, Piezoelectric Energy Harvester which protects the art of three-dimensional flexible circuitry in modern silicone hydrogel lenses. EPGL expects to report within the next quarterly update, a decision from USPTO on any additional patent allowance(s). EPGL will inform our shareholders via public release immediately upon receiving such notice from the USPTO .
On April 12, 2016 EPGL signed an Agreement with Johnson & Johnson Vision Care, Inc. (JNJVC) . In 2017, EPGL has added additional Agreements that allow EPGL to expand its ability to partner with InWith Corp, raise capital and establish additional commercialization partnerships and Agreements. There are several patents now pending in the field of ophthalmic technologies, specifically the integration of electronics into contact lenses for vision correction and augmented vision applications. EPGL has received four (4) USPTO patent allowances since our last updated disclosure.
https://www.otcmarkets.com/ajax/showFinancial...?id=180245
EPGL has received multiple USPTO patent allowances and has several more pending both in the US and International. The granted patents include the “Elastic Circuit”, Piezoelectric Energy Harvester which protects the art of three-dimensional flexible circuitry in modern silicone hydrogel lenses. EPGL expects to report within the next quarterly update, a decision from USPTO on any additional patent allowance(s). EPGL will inform our shareholders via public release immediately upon receiving such notice from the USPTO .
On April 12, 2016 EPGL signed an Agreement with Johnson & Johnson Vision Care, Inc. (JNJVC) . In 2017, EPGL has added additional Agreements that allow EPGL to expand its ability to partner with InWith Corp, raise capital and establish additional commercialization partnerships and Agreements. There are several patents now pending in the field of ophthalmic technologies, specifically the integration of electronics into contact lenses for vision correction and augmented vision applications. EPGL has received four (4) USPTO patent allowances since our last updated disclosure.
https://www.otcmarkets.com/ajax/showFinancial...?id=180245
(0)
(0)Scroll down for more posts ▼
